during the first year after transplantation , 4 of 53 patients ( 7.5 percent ) in the acyclovir group had symptomatic cytomegalovirus disease , as compared with 15 of 51 ( 29 percent ) in the placebo group ( p = 0.002 ) .
C0001367
acyclovir
C0010823
cytomegalovirus disease